Category: Finance
Firetail spreads its wings into Newfoundland, rich in copper, zinc and silver mineralisation
Firetail Resources has signed a binding option to acquire up to 80% of the York Harbour copper-zinc-silver project Project contains VMS geology and is near [more…]
Top 10 at 11: This morning is all about techies and goldies and bears, oh my!
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning [more…]
Market Highlights: Wall Street at record high as Nvidia surpasses Apple; and 5 small caps to watch today
The S&P 500 notches its 25th record high this year Nvidia surpasses Apple to become the second most valuable company in the world And what’s [more…]
Investors bet big on Many Peaks’ gold prospects
Many Peaks Minerals raises $5.2m through strongly supported private placement Proceeds will accelerate exploration at the Odienné and Ferké gold projects in Cote d’Ivoire Drilling [more…]
Who Made the Gains? Here are May’s top ASX miners and explorers
Metals are booming again 13 resources winners with gains above 100% in May; a recent record 13 out of the 50 top performers last month [more…]
Want to limit your losses when the market drops? There’s an ETF (or three) for that
In the current unpredictable market, investors frequently look for ways to safeguard their portfolios Inverse ETFs offer a simple way to hedge against market drops, [more…]
Rise and Shine: Everything you need to know before the ASX opens
Good morning everyone, and welcome to 06 June, 2024 – an important day in the history of medicine, and a terrible day to be [more…]
Closing Bell: The good news is the ASX is higher. The better news is the economy’s shot
Aussie shares rise in arvo trade Resources sectors weigh, Real Estate adds 2pc GDP lowest in 40 years ex. COVID The local bourse has [more…]
PharmAust’s monepantel drug could be a game-changer for MND/ALS patients, new data shows
PharmAust reports promising updates on MPL’s efficacy in treating MND/ALS New data suggests MPL significantly reduces the risk of death by 91% in MND/ALS patients [more…]
Long Shortz with Belararox: Significant copper targets ready for drilling
Stockhead’s Sarah Hughan sits down with Belararox (ASX:BRX) managing director Arvind Misra to get the short end of the long story on the company’s latest news. [more…]
